{"id":268227,"date":"2020-09-10T02:09:48","date_gmt":"2020-09-10T06:09:48","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=268227"},"modified":"2020-09-10T02:09:48","modified_gmt":"2020-09-10T06:09:48","slug":"1-5k-pinoys-in-uae-join-sinopharms-vaccine-clinical-trials","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/09\/10\/1-5k-pinoys-in-uae-join-sinopharms-vaccine-clinical-trials\/","title":{"rendered":"1.5K Pinoys in UAE join Sinopharm&#8217;s vaccine clinical trials"},"content":{"rendered":"<figure id=\"attachment_266008\" aria-describedby=\"caption-attachment-266008\" style=\"width: 1280px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-266008\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280.jpg\" alt=\"\" width=\"1280\" height=\"720\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280.jpg 1280w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280-300x169.jpg 300w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280-768x432.jpg 768w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/syringe-3359627_1280-1024x576.jpg 1024w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/a><figcaption id=\"caption-attachment-266008\" class=\"wp-caption-text\">The candidate vaccine is expected to enter similar last stage evaluations in Bahrain, Argentina, Peru, and Morocco, involving more than 50,000 volunteers from 115 countries. (Pixabay photo)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0&#8212;\u00a0Some 1,500 Filipinos in the United Arab Emirates (UAE) participated in Sinopharm&#8217;s clinical trial for its candidate vaccine against the coronavirus disease 2019 (Covid-19), the Chinese Embassy in Manila confirmed Wednesday.<\/p>\n<p>In a statement quoting Ambassador Huang Xilian, the Embassy said the 1,500 Filipinos are among the more than 30,000 volunteers who joined the Chinese company&#8217;s phase III clinical trial, which started on June 23, in the Gulf state.<\/p>\n<p>The candidate vaccine is expected to enter similar last stage evaluations in Bahrain, Argentina, Peru, and Morocco, involving more than 50,000 volunteers from 115 countries.<\/p>\n<p>According to the Embassy, over &#8220;hundreds of thousands of people&#8221; have been inoculated with Sinopharm\u2019s vaccine since China launched the emergency use of Covid-19 (coronavirus disease 2019) vaccines on July 22, &#8220;with no cases of severe adverse effects or infection&#8221;.<\/p>\n<p>The Embassy added that relevant tests of Sinopharm\u2019s vaccine against major SARS-CoV-2 strains, including those from Beijing Xinfadi as well as other regions of Russia, the United Kingdom, the United States, and Austria showed &#8220;promising results&#8221; in both safety and efficacy.<\/p>\n<p>The Chinese candidate vaccine is expected to be on the market by the end of December 2020, said the Embassy, adding that the company has built two high-level biosafety production facilities both in Beijing and Wuhan, with an annual production capacity of 300 million doses.<\/p>\n<p>&#8220;With the expansion of production capacity, the annual output will reach 800 million to 1 billion doses in the future,&#8221; it said.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0&#8212;\u00a0Some 1,500 Filipinos in the United Arab Emirates (UAE) participated in Sinopharm&#8217;s clinical trial for its candidate vaccine against the &hellip;<\/p>\n","protected":false},"author":33,"featured_media":266008,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1145,16,95],"tags":[],"class_list":["post-268227","post","type-post","status-publish","format-standard","has-post-thumbnail","category-headline","category-news","category-news-ph","mauthors-joyce-ann-l-rocamora","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/268227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=268227"}],"version-history":[{"count":2,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/268227\/revisions"}],"predecessor-version":[{"id":268229,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/268227\/revisions\/268229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/266008"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=268227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=268227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=268227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}